• Exchange: Berlin
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Entest BioMedical Inc

+ Add to Watchlist


Price not available for E9B:GR

Snapshot for Entest BioMedical Inc (E9B)

Open: - Day's Range: - Volume: 0
Previous Close: 0.002 52wk Range: - 1-Yr Rtn: -

Stock Chart for E9B

No chart data available.
  • E9B:GR 0.002
  • 1M
  • 1Y
Interactive E9B Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for E9B

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. DAX -
Earnings Per Share (ttm) -
Est. EPS -
Est. PEG Ratio -
Market Cap (M EUR) 0.00
Shares Outstanding (M) 1,998.07
30 Day Average Volume -
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for E9B

No data available

Company Profile & Key Executives for E9B

Entest BioMedical, Inc. researches stem cell therapies for traumatic brain injuries, diabetes testing, and medical devices.

David R KoosChairman/CEOTammy L ReynoldsChief Financial Officer
Feng LinDir:Research
More Company Profile & Key Executives for E9B

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil